50847-11-5 | 1-Propanone, 2-methyl-1-[2-(1-methylethyl)pyrazolo[1,5-a]pyridin-3-yl]-

Packsize	Purity	Availability	Price	Discounted Price
20mg	95%	in stock	$39.00	$27.00
100mg	95%	in stock	$40.00	$28.00
250mg	95%	in stock	$73.00	$51.00
1g	95%	in stock	$134.00	$94.00
5g	95%	in stock	$443.00	$310.00
10g	95%	in stock	$813.00	$569.00
25g	95%	in stock	$1,488.00	$1,042.00

Description

• Catalog Number: AI51420
• Chemical Name: 1-Propanone, 2-methyl-1-[2-(1-methylethyl)pyrazolo[1,5-a]pyridin-3-yl]-
• CAS Number: 50847-11-5
• Molecular Formula: C14H18N2O
• Molecular Weight: 230.3055
• MDL Number: MFCD00864808
• SMILES: CC(C(=O)c1c(nn2c1cccc2)C(C)C)C

Computed Properties

• Complexity: 288
• Covalently-Bonded Unit Count: 1
• Heavy Atom Count: 17
• Hydrogen Bond Acceptor Count: 2
• Rotatable Bond Count: 3
• XLogP3: 3

Literature

• Phase 2 Trial of Ibudilast in Progressive Multiple Sclerosis.

  The New England journal of medicine 20180830

• Inhibition of paclitaxel-induced decreases in calcium signaling.

  The Journal of biological chemistry 20121102

• Prevention of paclitaxel-induced peripheral neuropathy by lithium pretreatment.

  FASEB journal : official publication of the Federation of American Societies for Experimental Biology 20121101

• The glial cell modulators, ibudilast and its amino analog, AV1013, attenuate methamphetamine locomotor activity and its sensitization in mice.

  European journal of pharmacology 20120315

• Phosphodiesterase inhibitors. Part 1: Synthesis and structure-activity relationships of pyrazolopyridine-pyridazinone PDE inhibitors developed from ibudilast.

  Bioorganic & medicinal chemistry letters 20110601

• Ibudilast, a mixed PDE3/4 inhibitor, causes a selective and nitric oxide/cGMP-independent relaxation of the intracranial vertebrobasilar artery.

  European journal of pharmacology 20110115

• [Chronic subdural hematoma--recurrence and prevention].

  Brain and nerve = Shinkei kenkyu no shinpo 20110101

• Ibudilast, a pharmacologic phosphodiesterase inhibitor, prevents human immunodeficiency virus-1 Tat-mediated activation of microglial cells.

  PloS one 20110101

• The glial cell modulator and phosphodiesterase inhibitor, AV411 (ibudilast), attenuates prime- and stress-induced methamphetamine relapse.

  European journal of pharmacology 20100710

• Allosteric inhibition of macrophage migration inhibitory factor revealed by ibudilast.

  Proceedings of the National Academy of Sciences of the United States of America 20100622

• Determination of ibudilast in human serum by high-performance liquid chromatography for pharmacokinetic study.

  Biomedical chromatography : BMC 20100301

• Ibudilast inhibits cerebral aneurysms by down-regulating inflammation-related molecules in the vascular wall of rats.

  Neurosurgery 20100301

• Mining biologically-active molecules for inhibitors of fatty acid amide hydrolase (FAAH): identification of phenmedipham and amperozide as FAAH inhibitors.

  Bioorganic & medicinal chemistry letters 20091201

• Modulation of morphine-induced antinociception in acute and chronic opioid treatment by ibudilast.

  Anesthesiology 20091201

• Vasodilator effects of ibudilast on retinal blood vessels in anesthetized rats.

  Biological & pharmaceutical bulletin 20091101

• The glial activation inhibitor AV411 reduces morphine-induced nucleus accumbens dopamine release.

  Brain, behavior, and immunity 20090501

• Reduction of opioid withdrawal and potentiation of acute opioid analgesia by systemic AV411 (ibudilast).

  Brain, behavior, and immunity 20090201

• [Clinical research of Ibudilast on treating the steroid resistant allergic rhinitis].

  Lin chuang er bi yan hou tou jing wai ke za zhi = Journal of clinical otorhinolaryngology, head, and neck surgery 20090101

• Recent advances on phosphodiesterase 4 inhibitors for the treatment of asthma and chronic obstructive pulmonary disease.

  Journal of medicinal chemistry 20080925

• Evidence for a role for cyclic AMP in modulating the action of 5-HT and an excitatory neuropeptide, FLP17A, in the pharyngeal muscle of Caenorhabditis elegans.

  Invertebrate neuroscience : IN 20080601

• Spontaneous resolution of isolated dissecting aneurysm on the posterior inferior cerebellar artery.

  Acta neurochirurgica 20080101

• Ibudilast-induced decreases in cytosolic Ca(2+) level and contraction in rat aorta.

  Journal of pharmacological sciences 20070801

• Ibudilast (AV-411). A new class therapeutic candidate for neuropathic pain and opioid withdrawal syndromes.

  Expert opinion on investigational drugs 20070701

• Pain management research goes beyond the obvious.

  American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 20061201

• [Treatment by medicine which improves cerebral circulation and metabolism].

  Nihon rinsho. Japanese journal of clinical medicine 20061128

• [Nicergoline, ibudilast, ifenprodil tartrate].

  Nihon rinsho. Japanese journal of clinical medicine 20061028

• Preferential inhibition of human phosphodiesterase 4 by ibudilast.

  Life sciences 20060501

• Microsphere-based protease assays and screening application for lethal factor and factor Xa.

  Cytometry. Part A : the journal of the International Society for Analytical Cytology 20060501

• Phosphodiesterase inhibitors suppress IL-12 production with microglia and T helper 1 development.

  Multiple sclerosis (Houndmills, Basingstoke, England) 20031201

• Relaxation and potentiation of cGMP-mediated response by ibudilast in bovine tracheal smooth muscle.

  Naunyn-Schmiedeberg's archives of pharmacology 20020901

• Sustained ER Ca2+ depletion suppresses protein synthesis and induces activation-enhanced cell death in mast cells.

  The Journal of biological chemistry 20020419

• Inhibitory effect of ibudilast on urinary albumin excretion in type 2 diabetes mellitus with microalbuminuria.

  Nephron 20020201

• Ménière's disease in childhood.

  International journal of pediatric otorhinolaryngology 20011201

• Ibudilast attenuates astrocyte apoptosis via cyclic GMP signalling pathway in an in vitro reperfusion model.

  British journal of pharmacology 20010701

• Potentiation of ibudilast inhibition of platelet aggregation in the presence of endothelial cells.

  Thrombosis research 20010501

• Ibudilast: a non-selective PDE inhibitor with multiple actions on blood cells and the vascular wall.

  Cardiovascular drug reviews 20010101